COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
FDA Approves First Gene Therapy for Rare Neurodegenerative Disease
September 20, 2022
AABB Issues Interim Standards to 33rd Edition of BBTS Standards
September 09, 2022
REGULATORY UPDATE: FDA Issues New Monkeypox Information for Human Cells and Tissues
August 31, 2022
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977